These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 33280613)

  • 1. Targeting neuroplasticity in patients with neurodegenerative diseases using brain stimulation techniques.
    Yuan TF; Li WG; Zhang C; Wei H; Sun S; Xu NJ; Liu J; Xu TL
    Transl Neurodegener; 2020 Dec; 9(1):44. PubMed ID: 33280613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation.
    Jakobs M; Lee DJ; Lozano AM
    Neuropharmacology; 2020 Jul; 171():107860. PubMed ID: 31765650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkinetic disorders and loss of synaptic downscaling.
    Calabresi P; Pisani A; Rothwell J; Ghiglieri V; Obeso JA; Picconi B
    Nat Neurosci; 2016 Jun; 19(7):868-75. PubMed ID: 27351172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques.
    Pilato F; Profice P; Ranieri F; Capone F; Di Iorio R; Florio L; Di Lazzaro V
    Mol Neurobiol; 2012 Dec; 46(3):563-71. PubMed ID: 22821187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining functional imaging with brain stimulation in Parkinson's disease.
    Obeso I; Ray NJ; Antonelli F; Cho SS; Strafella AP
    Int Rev Psychiatry; 2011 Oct; 23(5):467-75. PubMed ID: 22200136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: Clinical Effects and Future Perspectives.
    Chen KS; Chen R
    Clin Pharmacol Ther; 2019 Oct; 106(4):763-775. PubMed ID: 31179534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer's disease.
    Boggio PS; Valasek CA; Campanhã C; Giglio AC; Baptista NI; Lapenta OM; Fregni F
    Neuropsychol Rehabil; 2011 Oct; 21(5):703-16. PubMed ID: 21942868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulation Approaches in Parkinson's Disease Using Deep Brain Stimulation and Transcranial Magnetic Stimulation.
    Cleary RT; Bucholz R
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):301-309. PubMed ID: 34219521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial.
    Ponce FA; Asaad WF; Foote KD; Anderson WS; Rees Cosgrove G; Baltuch GH; Beasley K; Reymers DE; Oh ES; Targum SD; Smith GS; Lyketsos CG; Lozano AM;
    J Neurosurg; 2016 Jul; 125(1):75-84. PubMed ID: 26684775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's disease and dystonia.
    Rothwell J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S417-20. PubMed ID: 18267274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation: potential for neuroprotection.
    McKinnon C; Gros P; Lee DJ; Hamani C; Lozano AM; Kalia LV; Kalia SK
    Ann Clin Transl Neurol; 2019 Jan; 6(1):174-185. PubMed ID: 30656196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of repetitive transcranial magnetic stimulation in patients with neurodegenerative diseases - clinician's perspective.
    Anderkova L; Rektorova I
    J Neurol Sci; 2014 Apr; 339(1-2):15-25. PubMed ID: 24530170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson's and Alzheimer's Disease Therapy.
    Senevirathne DKL; Mahboob A; Zhai K; Paul P; Kammen A; Lee DJ; Yousef MS; Chaari A
    Cells; 2023 May; 12(11):. PubMed ID: 37296599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation for dementias.
    Xu DS; Ponce FA
    Neurosurg Focus; 2018 Aug; 45(2):E8. PubMed ID: 30064323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDTD-based Transcranial Magnetic Stimulation model applied to specific neurodegenerative disorders.
    Fanjul-Vélez F; Salas-García I; Ortega-Quijano N; Arce-Diego JL
    Comput Methods Programs Biomed; 2015 Jan; 118(1):34-43. PubMed ID: 25453382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease.
    Nardone R; Tezzon F; Höller Y; Golaszewski S; Trinka E; Brigo F
    Acta Neurol Scand; 2014 Jun; 129(6):351-66. PubMed ID: 24506061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive brain stimulation for Parkinson's disease: Current concepts and outlook 2015.
    Benninger DH; Hallett M
    NeuroRehabilitation; 2015; 37(1):11-24. PubMed ID: 26409690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cerebellar neuromodulation in movement disorders: A systematic review.
    França C; de Andrade DC; Teixeira MJ; Galhardoni R; Silva V; Barbosa ER; Cury RG
    Brain Stimul; 2018; 11(2):249-260. PubMed ID: 29191439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of neuroplasticity induced by non-invasive brain stimulation: building models for the clinical use of CNS active drugs.
    Nitsche MA; Müller-Dahlhaus F; Paulus W; Ziemann U
    J Physiol; 2012 Oct; 590(19):4641-62. PubMed ID: 22869014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocols of non-invasive brain stimulation for neuroplasticity induction.
    He W; Fong PY; Leung TWH; Huang YZ
    Neurosci Lett; 2020 Feb; 719():133437. PubMed ID: 29476796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.